ENvue Medical (FEED) Return on Sales (2014 - 2026)

ENvue Medical (FEED) has 13 years of Return on Sales data on file, last reported at 0.06% in Q1 2026.

• Return on Sales for Q1 2026 came in at 0.06%, down 4.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.08% (up 8.0% YoY), and the FY2025 annual result was 0.07%, up 7.0% from the prior year.
• Return on Sales retreated to 0.06% in Q1 2026 per FEED's latest filing, from 0.78% in the prior quarter.
• Over five years, Return on Sales peaked at 0.78% in Q4 2025 and troughed at 14.45% in Q4 2022.
• A 5-year average of 0.83% and a median of 0.03% in 2024 frame the typical range for Return on Sales.
• The sharpest annual moves came in 2022 and 2023: Return on Sales sank 1478 bps in 2022, then jumped 1447 bps in 2023.
• A 5-year view of Return on Sales shows it stood at 14.45% in 2022, then jumped by 100 bps to 0.02% in 2023, then surged by 108 bps to 0.05% in 2024, then soared by 1500 bps to 0.78% in 2025, then plunged by 107 bps to 0.06% in 2026.
• Business Quant data shows FEED's Return on Sales at 0.06% in Q1 2026, 0.78% in Q4 2025, and 0.01% in Q3 2025.